These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28514203)

  • 1. Cost-effectiveness of MR Imaging-guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men.
    Pahwa S; Schiltz NK; Ponsky LE; Lu Z; Griswold MA; Gulani V
    Radiology; 2017 Oct; 285(1):157-166. PubMed ID: 28514203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
    de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
    Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS).
    Faria R; Soares MO; Spackman E; Ahmed HU; Brown LC; Kaplan R; Emberton M; Sculpher MJ
    Eur Urol; 2018 Jan; 73(1):23-30. PubMed ID: 28935163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer.
    Cerantola Y; Dragomir A; Tanguay S; Bladou F; Aprikian A; Kassouf W
    Urol Oncol; 2016 Mar; 34(3):119.e1-9. PubMed ID: 26602178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Men with Low-risk Prostate Cancer: A Cost-effectiveness Modeling Study.
    Patel S; Rongen JJ; Fütterer JJ; Boltyenkov A; Rovers MM
    Eur Urol Oncol; 2018 Dec; 1(6):476-483. PubMed ID: 31158091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Comparison of Imaging-Guided Prostate Biopsy Techniques: Systematic Transrectal Ultrasound, Direct In-Bore MRI, and Image Fusion.
    Venderink W; Govers TM; de Rooij M; Fütterer JJ; Sedelaar JPM
    AJR Am J Roentgenol; 2017 May; 208(5):1058-1063. PubMed ID: 28225639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer.
    Barnett CL; Davenport MS; Montgomery JS; Wei JT; Montie JE; Denton BT
    BJU Int; 2018 Jul; 122(1):50-58. PubMed ID: 29388388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of multiparametric magnetic resonance imaging and MRI-guided biopsy in a population-based prostate cancer screening setting using a micro-simulation model.
    Getaneh AM; Heijnsdijk EA; de Koning HJ
    Cancer Med; 2021 Jun; 10(12):4046-4053. PubMed ID: 33991077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
    Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
    Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results.
    Yun H; Kim J; Gandhe A; Nelson B; Hu JC; Gulani V; Margolis D; Schackman BR; Jalali A
    JAMA Netw Open; 2023 Nov; 6(11):e2344856. PubMed ID: 38019516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.
    Kuhl CK; Bruhn R; Krämer N; Nebelung S; Heidenreich A; Schrading S
    Radiology; 2017 Nov; 285(2):493-505. PubMed ID: 28727544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
    Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
    Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy.
    Lotan Y; Haddad AQ; Costa DN; Pedrosa I; Rofsky NM; Roehrborn CG
    Urol Oncol; 2015 Jun; 33(6):266.e9-16. PubMed ID: 25858102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.
    Verma S; Choyke PL; Eberhardt SC; Oto A; Tempany CM; Turkbey B; Rosenkrantz AB
    Radiology; 2017 Nov; 285(2):343-356. PubMed ID: 29045233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Bore 3-T MR-guided Transrectal Targeted Prostate Biopsy: Prostate Imaging Reporting and Data System Version 2-based Diagnostic Performance for Detection of Prostate Cancer.
    Tan N; Lin WC; Khoshnoodi P; Asvadi NH; Yoshida J; Margolis DJ; Lu DS; Wu H; Sung KH; Lu DY; Huang J; Raman SS
    Radiology; 2017 Apr; 283(1):130-139. PubMed ID: 27861110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis.
    Sathianathen NJ; Kuntz KM; Alarid-Escudero F; Lawrentschuk NL; Bolton DM; Murphy DG; Weight CJ; Konety BR
    J Urol; 2018 Dec; 200(6):1215-1220. PubMed ID: 29906434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography].
    Durmus T; Stephan C; Grigoryev M; Diederichs G; Saleh M; Slowinski T; Maxeiner A; Thomas A; Fischer T
    Rofo; 2013 May; 185(5):428-33. PubMed ID: 23420313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.